Literature DB >> 9362449

Induced direct binding of the adapter protein Nck to the GTPase-activating protein-associated protein p62 by epidermal growth factor.

J Tang1, G S Feng, W Li.   

Abstract

The SH3-SH3-SH3-SH2 adapter protein Nck links receptor tyrosine kinases, such as EGF and PDGF receptors, to downstream signaling pathways, among which p21cdc42/rac-activated kinase cascade, Sos-activated Ras signaling and the human Wiskott-Aldrich Syndrome protein (WASp)-mediated actin cytoskeleton changes, have been implicated. In EGF stimulated cells, Nck co-immunoprecipitates with a number of phosphotyrosine proteins including the EGF receptor (Li et al., 1992 Mol. Cell. Biol. 12: 5824-2833). To identify the phosphotyrosine protein(s) that directly interacts with Nck and to distinguish it from indirectly associated proteins, preexisting phosphoytrosine protein complexes in the cell lysate were dissociated by heat and SDS prior to the test for binding to Nck. We found that Nck does not directly bind to EGF receptor, instead it binds via its SH2 domain to a 62 kDa phosphotyrosine protein. We present evidence demonstrating that the Nck-bound p62 is related to the previously identified GTPase-activating protein (GAP)-associated phosphotyrosine protein p62. (1) The Nck-bound and the GAP-bound p62 proteins co-migrate with each other in SDS-PAGE. (2) SH2 domains from Nck and GAP compete for binding to p62 in vitro. (3) Purified GST-Nck-SH2 binds directly to the GAP-associated p62. Under these conditions, SH2 domains from PLCgamma, PI-3 kinase, SHC, and Grb2 did not bind p62. (4) Tryptic phosphopeptide maps of the Nck- and the GAP-associated p62 proteins are identical. However, Nck and GAP do not co-immunoprecipitate with each other and apparently bind to different pools of p62. This study suggests that the GAP-associated p62 acts as an SH2 domain docking protein and mediates the interaction between Nck and EGF receptor in response to EGF stimulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362449     DOI: 10.1038/sj.onc.1201351

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling.

Authors:  S Lemay; D Davidson; S Latour; A Veillette
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Inhibition of the motility and growth of B16F10 mouse melanoma cells by dominant negative mutants of Dok-1.

Authors:  T Hosooka; T Noguchi; H Nagai; T Horikawa; T Matozaki; M Ichihashi; M Kasuga
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  Modulation of protein translation by Nck-1.

Authors:  Sem Kebache; Dongmei Zuo; Eric Chevet; Louise Larose
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

4.  Angiotensin II stimulates serine phosphorylation of the adaptor protein Nck: physical association with the serine/threonine kinases Pak1 and casein kinase I.

Authors:  L Voisin; L Larose; S Meloche
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

5.  The Drosophila HEM-2/NAP1 homolog KETTE controls axonal pathfinding and cytoskeletal organization.

Authors:  T Hummel; K Leifker; C Klämbt
Journal:  Genes Dev       Date:  2000-04-01       Impact factor: 11.361

6.  Nck-2, a novel Src homology2/3-containing adaptor protein that interacts with the LIM-only protein PINCH and components of growth factor receptor kinase-signaling pathways.

Authors:  Y Tu; F Li; C Wu
Journal:  Mol Biol Cell       Date:  1998-12       Impact factor: 4.138

7.  Regulation of process retraction and cell migration by EphA3 is mediated by the adaptor protein Nck1.

Authors:  Tianjing Hu; Guanfang Shi; Louise Larose; Gonzalo M Rivera; Bruce J Mayer; Renping Zhou
Journal:  Biochemistry       Date:  2009-07-14       Impact factor: 3.162

8.  Expression of G3BP and RhoC in esophageal squamous carcinoma and their effect on prognosis.

Authors:  Hui-Zhong Zhang; Jin-Geng Liu; Yi-Ping Wei; Cheng Wu; Yong-Ke Cao; Mei Wang
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

9.  p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl).

Authors:  A Di Cristofano; M Niki; M Zhao; F G Karnell; B Clarkson; W S Pear; L Van Aelst; P P Pandolfi
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

10.  c-Abl phosphorylates Dok1 to promote filopodia during cell spreading.

Authors:  Pamela J Woodring; Jill Meisenhelder; Sam A Johnson; Guo-Lei Zhou; Jeffrey Field; Kavita Shah; Friedhelm Bladt; Tony Pawson; Masaru Niki; Pier Paolo Pandolfi; Jean Y J Wang; Tony Hunter
Journal:  J Cell Biol       Date:  2004-05-17       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.